136 related articles for article (PubMed ID: 38591816)
1. Accrual Quality Improvement Program for clinical trials.
Richmond E; Samimi G; House M; Ford LG; Szabo E
Clin Trials; 2024 Apr; ():17407745241243027. PubMed ID: 38591816
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis Study.
Applequist J; Burroughs C; Merkel PA; Rothenberg M; Trapnell B; Desnick R; Sahin M; Krischer J
J Med Internet Res; 2023 Mar; 25():e39262. PubMed ID: 36917158
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.
Liu J; Wick JA; Mudaranthakam DP; Jiang Y; Mayo MS; Gajewski BJ
Clin Trials; 2019 Dec; 16(6):657-664. PubMed ID: 31451012
[TBL] [Abstract][Full Text] [Related]
7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
9. Participant Recruitment and Engagement in Automated eHealth Trial Registration: Challenges and Opportunities for Recruiting Women Who Experience Violence.
Koziol-McLain J; McLean C; Rohan M; Sisk R; Dobbs T; Nada-Raja S; Wilson D; Vandal AC
J Med Internet Res; 2016 Oct; 18(10):e281. PubMed ID: 27780796
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials site recruitment optimisation: Guidance from Clinical Trials: Impact and Quality.
Zahren C; Harvey S; Weekes L; Bradshaw C; Butala R; Andrews J; O'Callaghan S
Clin Trials; 2021 Oct; 18(5):594-605. PubMed ID: 34041937
[TBL] [Abstract][Full Text] [Related]
13. Accelerating cancer clinical trial recruitment through a financial reimbursement program integrated with patient navigation: an interrupted time series analysis.
Borno HT; Lin TK; Zhang S; Skafel A; Lalanne A; Dornsife D; Johnson R; Spicer D; Small EJ; Rhoads KF
J Cancer Policy; 2021 Dec; 30():100305. PubMed ID: 35559801
[TBL] [Abstract][Full Text] [Related]
14. Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.
Pemberton VL; Evans F; Gulin J; Rosenberg E; Addou E; Burns KM; Gordon DJ; Pearson GD; Kaltman JR
Clin Trials; 2018 Oct; 15(5):444-451. PubMed ID: 30084662
[TBL] [Abstract][Full Text] [Related]
15. Monitoring strategies for clinical intervention studies.
Klatte K; Pauli-Magnus C; Love SB; Sydes MR; Benkert P; Bruni N; Ewald H; Arnaiz Jimenez P; Bonde MM; Briel M
Cochrane Database Syst Rev; 2021 Dec; 12(12):MR000051. PubMed ID: 34878168
[TBL] [Abstract][Full Text] [Related]
16. Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.
Dew A; Khan S; Babinski C; Michel N; Heffernan M; Stephan S; Jordan N; Jovanovic B; Carney P; Bergan R
Clin Trials; 2013 Apr; 10(2):292-9. PubMed ID: 23321266
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
[TBL] [Abstract][Full Text] [Related]
18. Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment.
Kirn DR; Grill JD; Aisen P; Ernstrom K; Gale S; Heidebrink J; Jicha G; Jimenez-Maggiora G; Johnson L; Peskind E; McCann K; Shaffer E; Sultzer D; Wang S; Sperling R; Raman R
Alzheimers Res Ther; 2023 May; 15(1):88. PubMed ID: 37131229
[TBL] [Abstract][Full Text] [Related]
19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
